Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Samer Al Hadidi

Concepts (181)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
38
2024
2915
7.400
Why?
Hematologic Neoplasms
5
2024
98
3.090
Why?
Immunotherapy, Adoptive
10
2025
158
3.060
Why?
Antibodies, Bispecific
5
2024
70
2.800
Why?
Hematopoietic Stem Cell Transplantation
7
2024
554
2.780
Why?
Hematology
3
2024
25
2.610
Why?
Medical Oncology
6
2024
95
2.520
Why?
Neoplasms
8
2024
1233
2.450
Why?
Clinical Trials as Topic
6
2024
466
2.440
Why?
Hodgkin Disease
3
2021
44
2.110
Why?
Drug Approval
5
2024
47
1.960
Why?
Neoplasm Recurrence, Local
6
2024
626
1.930
Why?
Humans
71
2025
49898
1.890
Why?
Neutropenia
2
2023
114
1.590
Why?
Waldenstrom Macroglobulinemia
2
2022
40
1.540
Why?
Physicians
3
2024
229
1.510
Why?
Transplantation, Autologous
7
2024
462
1.440
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2024
994
1.310
Why?
T-Lymphocytes
6
2024
328
1.290
Why?
Neoplasms, Second Primary
2
2024
74
1.090
Why?
Neoplasms, Plasma Cell
2
2024
35
1.060
Why?
Cross-Sectional Studies
8
2024
1573
1.050
Why?
United States Food and Drug Administration
6
2024
91
1.010
Why?
United States
13
2024
4878
0.960
Why?
Receptors, G-Protein-Coupled
2
2024
53
0.950
Why?
Authorship
1
2024
12
0.930
Why?
Autoimmune Diseases
1
2025
81
0.910
Why?
Ubiquitin-Protein Ligases
1
2024
93
0.890
Why?
Antibodies, Monoclonal, Humanized
3
2023
223
0.870
Why?
Terminology as Topic
1
2023
63
0.870
Why?
Awards and Prizes
1
2023
18
0.840
Why?
Fractures, Spontaneous
1
2022
14
0.820
Why?
Tomography, X-Ray Computed
3
2017
1150
0.820
Why?
Periodicals as Topic
1
2022
57
0.790
Why?
Thalidomide
1
2024
374
0.790
Why?
Lymphoma, B-Cell
1
2022
61
0.780
Why?
Patient Participation
1
2022
67
0.760
Why?
Bone Diseases
1
2022
97
0.750
Why?
Venous Thromboembolism
1
2022
67
0.750
Why?
Brain Diseases
1
2021
80
0.740
Why?
Antibodies, Monoclonal
3
2024
457
0.730
Why?
Programmed Cell Death 1 Receptor
1
2020
40
0.710
Why?
Practice Guidelines as Topic
1
2023
458
0.700
Why?
Racism
1
2021
57
0.680
Why?
Atrial Fibrillation
1
2022
182
0.670
Why?
Quality of Life
2
2022
837
0.640
Why?
Healthcare Disparities
1
2022
279
0.640
Why?
Receptors, Antigen, T-Cell
3
2024
49
0.630
Why?
Platinum Compounds
1
2018
11
0.610
Why?
Mycosis Fungoides
1
2018
28
0.600
Why?
Subclavian Artery
1
2017
19
0.590
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2017
7
0.590
Why?
Pregnancy Complications, Neoplastic
1
2018
24
0.590
Why?
Pruritus
1
2018
44
0.590
Why?
Antithrombin III Deficiency
1
2017
3
0.590
Why?
Ulcer
1
2017
23
0.570
Why?
Lymphoproliferative Disorders
1
2017
26
0.570
Why?
Tachycardia, Ventricular
1
2017
43
0.570
Why?
Epstein-Barr Virus Infections
1
2017
29
0.570
Why?
Female
14
2025
26560
0.570
Why?
Combined Modality Therapy
4
2024
638
0.560
Why?
Abdominal Pain
1
2017
84
0.560
Why?
Colon
1
2017
96
0.560
Why?
Thromboembolism
1
2017
54
0.560
Why?
Deglutition Disorders
1
2017
75
0.550
Why?
Dexamethasone
3
2024
424
0.530
Why?
Diagnosis, Differential
5
2018
1036
0.530
Why?
Gangrene
1
2016
14
0.530
Why?
Carcinoma, Non-Small-Cell Lung
1
2018
153
0.520
Why?
Immunosuppressive Agents
1
2017
226
0.520
Why?
Penile Diseases
1
2016
16
0.510
Why?
Adult
10
2025
13346
0.510
Why?
Aspirin
1
2016
111
0.500
Why?
Leiomyoma
1
2015
25
0.490
Why?
Migraine with Aura
1
2014
4
0.490
Why?
Hysterectomy
1
2015
88
0.480
Why?
Edema
1
2015
68
0.470
Why?
Early Diagnosis
1
2014
87
0.470
Why?
Carotid Stenosis
1
2014
64
0.460
Why?
Ovarian Neoplasms
1
2018
450
0.450
Why?
Brain Ischemia
1
2014
157
0.430
Why?
Melphalan
3
2023
173
0.430
Why?
Skin Neoplasms
1
2018
487
0.410
Why?
Middle Aged
7
2025
12285
0.410
Why?
Renal Insufficiency, Chronic
1
2015
170
0.400
Why?
Monoclonal Gammopathy of Undetermined Significance
2
2023
111
0.400
Why?
Antineoplastic Agents
1
2020
1175
0.390
Why?
Lung Neoplasms
1
2018
600
0.390
Why?
Myeloid Differentiation Factor 88
2
2022
33
0.390
Why?
Treatment Outcome
5
2025
5176
0.360
Why?
B-Cell Maturation Antigen
4
2024
88
0.360
Why?
Randomized Controlled Trials as Topic
4
2023
550
0.360
Why?
Diabetes Mellitus, Type 2
1
2016
483
0.340
Why?
Stroke
1
2014
478
0.330
Why?
Male
7
2025
25437
0.320
Why?
Prognosis
3
2024
1956
0.320
Why?
Survival Analysis
2
2023
670
0.320
Why?
Breast Neoplasms
1
2018
1183
0.310
Why?
Conflict of Interest
2
2024
25
0.290
Why?
Pulmonary Emphysema
1
2017
24
0.290
Why?
Risk Factors
4
2023
3604
0.280
Why?
Drug Resistance, Neoplasm
2
2020
314
0.280
Why?
Tumor Microenvironment
3
2023
221
0.270
Why?
Mutation
2
2022
1292
0.260
Why?
Plasma Cells
2
2024
221
0.260
Why?
Syndrome
2
2021
237
0.250
Why?
Career Choice
2
2024
110
0.250
Why?
Phthalimides
1
2024
4
0.240
Why?
Piperidones
1
2024
5
0.240
Why?
Drug Industry
1
2024
38
0.230
Why?
Morpholines
1
2024
66
0.230
Why?
Adaptor Proteins, Signal Transducing
1
2024
197
0.220
Why?
Molecular Targeted Therapy
1
2024
121
0.220
Why?
Financing, Organized
1
2023
13
0.210
Why?
Societies, Medical
1
2024
177
0.210
Why?
Neoplasm, Residual
2
2022
156
0.210
Why?
Fellowships and Scholarships
1
2024
118
0.210
Why?
Health Facilities
1
2023
40
0.210
Why?
Certification
1
2022
49
0.200
Why?
Faculty
1
2022
72
0.200
Why?
Patients
1
2022
47
0.200
Why?
Geography
1
2022
61
0.200
Why?
Social Media
1
2024
98
0.200
Why?
Animals
4
2024
13100
0.200
Why?
Paraproteinemias
1
2022
71
0.200
Why?
Blood Coagulation
1
2022
58
0.200
Why?
Immunoconjugates
1
2022
38
0.200
Why?
Immunotherapy
1
2024
235
0.200
Why?
Patient Selection
1
2023
254
0.200
Why?
Transplantation Conditioning
1
2022
82
0.190
Why?
Phenylalanine
1
2022
127
0.190
Why?
Research Design
1
2023
344
0.190
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
84
0.190
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
103
0.180
Why?
Pyrimidines
1
2022
192
0.180
Why?
Maintenance Chemotherapy
1
2020
49
0.180
Why?
Protein Kinase Inhibitors
1
2022
205
0.180
Why?
Health Status Disparities
1
2022
196
0.170
Why?
Pain
1
2022
374
0.170
Why?
Disease Progression
2
2023
820
0.170
Why?
Anticoagulants
1
2022
253
0.170
Why?
Minority Groups
1
2020
130
0.160
Why?
Aged
2
2024
9447
0.160
Why?
Follow-Up Studies
1
2024
2175
0.160
Why?
Chemotherapy, Adjuvant
1
2018
121
0.150
Why?
Prospective Studies
1
2023
2345
0.150
Why?
Vomiting
1
2017
70
0.140
Why?
Electrocardiography
1
2017
256
0.130
Why?
Weight Loss
1
2017
241
0.130
Why?
Carotid Artery, Internal
1
2014
23
0.120
Why?
Endarterectomy, Carotid
1
2014
62
0.120
Why?
Cerebral Angiography
1
2014
97
0.120
Why?
Lower Extremity
1
2015
92
0.120
Why?
Aged, 80 and over
1
2020
3136
0.100
Why?
Pregnancy
1
2018
2468
0.090
Why?
Bone Marrow
2
2022
351
0.090
Why?
Young Adult
1
2018
4029
0.080
Why?
Radiography, Thoracic
1
2017
65
0.070
Why?
Equipment and Supplies
1
2024
16
0.060
Why?
Marketing
1
2024
22
0.060
Why?
Disclosure
1
2024
38
0.060
Why?
Cystatin M
1
2024
19
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
X-Ray Microtomography
1
2024
78
0.060
Why?
Antibodies
1
2024
151
0.050
Why?
Mice
2
2024
5658
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
92
0.050
Why?
Chromosome Deletion
1
2023
138
0.050
Why?
In Situ Hybridization, Fluorescence
1
2023
256
0.050
Why?
Disease-Free Survival
1
2022
450
0.050
Why?
Pharmaceutical Preparations
1
2022
76
0.050
Why?
Bone Marrow Transplantation
1
2022
112
0.050
Why?
Proportional Hazards Models
1
2022
404
0.050
Why?
Chromosome Aberrations
1
2023
295
0.050
Why?
Genomics
1
2023
284
0.050
Why?
Stem Cell Transplantation
1
2022
179
0.050
Why?
Proteasome Inhibitors
1
2021
104
0.040
Why?
Cohort Studies
1
2023
1403
0.040
Why?
Cell Line, Tumor
1
2023
1388
0.040
Why?
Recurrence
1
2021
658
0.040
Why?
Gene Expression Profiling
1
2023
1028
0.040
Why?
Al Hadidi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description